Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,559 | 687 | 96.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $412.85 | 23 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,533 | 70 | $0 (2023) |
| Biogen, Inc. | $1,020 | 69 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $804.23 | 81 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $684.53 | 53 | $0 (2023) |
| AbbVie Inc. | $674.59 | 34 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $418.55 | 28 | $0 (2022) |
| Acorda Therapeutics, Inc | $412.85 | 23 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $370.51 | 12 | $0 (2023) |
| Allergan, Inc. | $341.05 | 28 | $0 (2020) |
| Amneal Pharmaceuticals LLC | $322.76 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.71 | 1 | MDD US Operations, LLC ($17.71) |
| 2023 | $2,336 | 133 | Novartis Pharmaceuticals Corporation ($337.14) |
| 2022 | $1,461 | 74 | ABBVIE INC. ($248.25) |
| 2021 | $1,420 | 80 | Biogen, Inc. ($165.23) |
| 2020 | $1,130 | 74 | Allergan, Inc. ($252.78) |
| 2019 | $1,921 | 107 | GENZYME CORPORATION ($269.37) |
| 2018 | $1,776 | 102 | GENZYME CORPORATION ($453.69) |
| 2017 | $1,911 | 139 | GENZYME CORPORATION ($411.44) |
All Payment Transactions
710 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: AMANTADINE | ||||||
| 12/21/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $9.38 | General |
| Category: Neurology | ||||||
| 12/21/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: Neurology | ||||||
| 12/15/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: PAIN | ||||||
| 12/09/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: NEUROSCIENCE | ||||||
| 12/08/2023 | Amylyx Pharmaceuticals, Inc. | RELYVRIO (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $15.04 | General |
| Category: Neuroscience | ||||||
| 12/07/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: NEUROLOGY | ||||||
| 11/30/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Neurology | ||||||
| 11/18/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Sleep | ||||||
| 11/17/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: PAIN | ||||||
| 11/14/2023 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.98 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: Neurology | ||||||
| 11/11/2023 | MDD US Operations, LLC | GOCOVRI (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: NEUROLOGY | ||||||
| 11/09/2023 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $20.60 | General |
| 11/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Central Nervous System | ||||||
| 10/27/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Neurology | ||||||
| 10/26/2023 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Rare Disease | ||||||
| 10/24/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $25.65 | General |
| Category: Neuroscience | ||||||
| 10/19/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Neurology | ||||||
| 10/19/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: PAIN | ||||||
| 10/18/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $27.35 | General |
| 10/16/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $19.86 | General |
| Category: Sleep | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 642 | 818 | $449,139 | $87,434 |
| 2022 | 11 | 635 | 797 | $420,835 | $88,752 |
| 2021 | 11 | 602 | 738 | $362,984 | $82,343 |
| 2020 | 11 | 580 | 705 | $335,172 | $72,716 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 166 | 268 | $88,440 | $22,671 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 154 | 211 | $48,741 | $21,054 | 43.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 62 | 62 | $67,518 | $7,007 | 10.4% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 42 | 46 | $66,792 | $6,775 | 10.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 35 | 35 | $63,525 | $6,410 | 10.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 20 | 20 | $48,400 | $4,669 | 9.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 29 | $8,323 | $4,205 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 55 | $7,975 | $3,734 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,725 | $3,483 | 39.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 14 | 14 | $30,492 | $2,951 | 9.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,064 | $2,771 | 45.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 33 | 37 | $4,144 | $1,707 | 41.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 161 | 278 | $91,410 | $24,982 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 152 | 190 | $43,890 | $19,454 | 44.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 95 | 99 | $107,811 | $11,691 | 10.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 40 | $11,480 | $6,161 | 53.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 36 | 37 | $53,724 | $5,925 | 11.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 24 | 24 | $52,272 | $5,370 | 10.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $9,854 | $4,913 | 49.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 19 | 19 | $34,485 | $3,579 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $7,678 | $2,967 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 39 | $5,655 | $2,569 | 45.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 23 | 23 | $2,576 | $1,140 | 44.2% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 144 | 236 | $73,620 | $21,777 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 146 | 183 | $39,879 | $18,782 | 47.1% |
About Dr. Stephen Conway, M.D
Dr. Stephen Conway, M.D is a Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104866524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Conway, M.D has received a total of $11,972 in payments from pharmaceutical and medical device companies, with $17.71 received in 2024. These payments were reported across 710 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($11,559).
As a Medicare-enrolled provider, Conway has provided services to 2,459 Medicare beneficiaries, totaling 3,058 services with total Medicare billing of $331,246. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Hartford, CT
- Active Since 06/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1104866524
Products in Payments
- AUBAGIO (Drug) $910.32
- LEMTRADA (Drug) $618.55
- COPAXONE (Drug) $471.69
- RYTARY (Drug) $462.67
- UBRELVY (Drug) $408.52
- TYSABRI (Biological) $369.20
- TECFIDERA (Drug) $367.25
- QULIPTA (Drug) $358.85
- KESIMPTA (Drug) $310.08
- NURTEC ODT (Drug) $291.82
- GOCOVRI (Drug) $275.80
- NUEDEXTA (Drug) $232.98
- TROKENDI XR (Drug) $229.53
- AJOVY (Biological) $221.17
- Gamunex-C (Biological) $215.21
- AMPYRA (Drug) $213.75
- INBRIJA (Drug) $199.10
- SOLIRIS (Drug) $196.17
- Briviact (Drug) $184.86
- UPLIZNA (Drug) $168.19
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hartford
Dr. Tapan Mehta, M.b.b.s, M.B.B.S
Neurology — Payments: $31,259
Dr. Lawrence Bluth, M.d, M.D
Neurology — Payments: $14,628
Dr. Brian Wong, M.d, M.D
Neurology — Payments: $8,026
Keshav Rao, Md, MD
Neurology — Payments: $3,525
Alexis Demopoulos, Md, MD
Neurology — Payments: $3,008
Dr. Sadaf Khorasanizadeh, Md, MD
Neurology — Payments: $2,074